{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:05:40Z","timestamp":1753891540762,"version":"3.41.2"},"reference-count":16,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,12,24]],"date-time":"2021-12-24T00:00:00Z","timestamp":1640304000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>Glial fibrillary acidic protein astrocytopathy is an immunotherapy-responsive autoimmune disease of the central nervous system with various clinical manifestations; among these, there are few reports about area postrema syndrome (APS). The authors present the case of a female patient admitted to the hospital with intractable nausea and vomiting as the predominant symptom. The patient's cerebrospinal fluid was tested by cell-based assays (CBA) and found positive for the presence of anti-glial fibrillary acidic protein (GFAP) antibody, in addition, serological testing showed elevated levels of thyroglobulin and thyroperoxidase-specific antibodies. Brain and cervical MRI showed abnormally high signal on the T2 sequence in the dorsal medulla oblongata and right pontine arm. Therefore, the patient was diagnosed with autoimmune GFAP astrocytopathy. The symptoms improved rapidly after treatment with corticosteroids, and no recurrence has been observed thus far. APS may be a relatively rare clinical manifestation of GFAP astrocytopathy. Importantly, such presentation is challenging to correctly diagnose without typical MRI imaging findings. However, the detection of antibodies in the cerebrospinal fluid or serum may be valuable. Systemic and neurological autoimmunity often coexist, comprehensive antibody screening should be conducted.<\/jats:p>","DOI":"10.3389\/fneur.2021.803116","type":"journal-article","created":{"date-parts":[[2021,12,24]],"date-time":"2021-12-24T07:24:30Z","timestamp":1640330670000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy Associated With Area Postrema Syndrome: A Case Report"],"prefix":"10.3389","volume":"12","author":[{"given":"Xin","family":"Gao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guo-Dong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wu","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,12,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1001\/jamaneurol.2016.2549","article-title":"Autoimmune glial fibrillary acidic protein astrocytopathy","volume":"73","author":"Fang","year":"2016","journal-title":"J Am Med Assoc Neurol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1002\/ana.24881","article-title":"Glial fibrillary acidic protein immunoglobulin G as biomarker of autoimmune astrocytopathy: analysis of 102 patients","volume":"81","author":"Flanagan","year":"2017","journal-title":"Ann Neurol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jneuroim.2019.04.004","article-title":"Clinical characteristics of autoimmune GFAP astrocytopathy","volume":"332","author":"Kimura","year":"2019","journal-title":"J Neuroimmunol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1097\/WCO.0000000000000676","article-title":"Autoimmune glial fibrillary acidic protein astrocytopathy","volume":"32","author":"Kunchok","year":"2019","journal-title":"Curr Opin Neurol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/ene.13531","article-title":"Autoimmune glial fibrillary acidic protein astrocytopathy in Chinese patients: a retrospective study","volume":"25","author":"Long","year":"2018","journal-title":"Eur J Neurol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1002\/cne.11021","article-title":"Development of vimentin and glial fibrillary acidic protein immunoreactivities in the brain of gray mullet (Chelon labrosus), an advanced teleost","volume":"469","author":"Arochena","year":"2004","journal-title":"J Comp Neurol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1177\/0961203319888692","article-title":"Neuromyelitis optica spectrum disorder and systemic lupus erythematosus","volume":"28","author":"Thabah","year":"2019","journal-title":"Lupus."},{"key":"B8","doi-asserted-by":"publisher","first-page":"e1642","DOI":"10.1212\/WNL.0000000000006392","article-title":"Area postrema syndrome:frequency, criteria, and severity in AQP4-IgG\u2013positive NMOSD","volume":"91","author":"Shosha","year":"2018","journal-title":"Neurology."},{"key":"B9","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology."},{"key":"B10","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.cgh.2012.11.021","article-title":"Intractable nausea and vomiting from autoantibodies against a brain water channel","volume":"11","author":"Iorio","year":"2013","journal-title":"Clin Gastroenterol Hepatol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1177\/1352458518813105","article-title":"Area postrema syndrome: a short history of a pearl in demyelinating diseases","volume":"25","author":"Camara-Lemarroy","year":"2018","journal-title":"Multiple Sclerosis J."},{"key":"B12","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1001\/jamaneurol.2016.5441","article-title":"Association of extension of cervical cord lesion and area postrema syndrome with neuromyelitis optica spectrum disorder","volume":"74","author":"Dubey","year":"2017","journal-title":"J Am Med Assoc Neurol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1177\/1352458518817992","article-title":"Area postrema syndrome: another feature of anti-GFAP encephalomyelitis","volume":"26","author":"Ciron","year":"2019","journal-title":"Multiple Sclerosis J."},{"key":"B14","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1136\/jnnp-2018-318004","article-title":"Glial fibrillary acidic protein IgG related myelitis: characterisation and comparison with aquaporin-4-IgG myelitis","volume":"90","author":"Sechi","year":"2019","journal-title":"J Neurol Neurosurg Psychiatr."},{"key":"B15","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1177\/1352458519826489","article-title":"Area postrema syndrome in autoimmune GFAP astrocytopathy","volume":"26","author":"Sechi","year":"2020","journal-title":"Multiple Sclerosis."},{"key":"B16","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1159\/000479948","article-title":"Treatment of autoimmune glial fibrillary acidic protein astrocytopathy: follow-up in 7 cases","volume":"24","author":"Yang","year":"2017","journal-title":"Neuroimmunomodulation."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.803116\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,24]],"date-time":"2021-12-24T07:24:31Z","timestamp":1640330671000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.803116\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,24]]},"references-count":16,"alternative-id":["10.3389\/fneur.2021.803116"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2021.803116","relation":{},"ISSN":["1664-2295"],"issn-type":[{"type":"electronic","value":"1664-2295"}],"subject":[],"published":{"date-parts":[[2021,12,24]]},"article-number":"803116"}}